Thomas Barnes is the founder of Orna Therapeutics. Orna Therapeutics has raised $100M in total funding. Latest round: Series A. Based in Cambridge, USA.
Thomas M. Barnes, Ph.D., is the CEO of Orna Therapeutics, a biotechnology company based in Cambridge, Massachusetts. Orna Therapeutics focuses on developing a new class of fully engineered circular RNA therapeutics (oRNAs) to treat various diseases, including cancer, autoimmune disorders, and genetic conditions. The company launched with over $100 million raised, including an $80 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library